vs
Cloudflare, Inc.（NET）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Cloudflare, Inc.的1.3倍（$772.1M vs $614.5M），Revvity净利率更高（12.7% vs -2.0%，领先14.7%），Cloudflare, Inc.同比增速更快（33.6% vs 5.9%），Revvity自由现金流更多（$161.8M vs $105.2M），过去两年Cloudflare, Inc.的营收复合增速更高（27.4% vs 9.0%）
Cloudflare是总部位于美国加利福尼亚州旧金山的科技企业，提供内容分发网络（CDN）、云网络安全、DDoS防护等多元互联网服务，同时是ICANN认证的域名注册商。其服务作为网站访客与客户托管服务商之间的反向代理，可有效提升访问性能，抵御恶意流量。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NET vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.3倍
$614.5M
营收增速更快
NET
高出27.8%
5.9%
净利率更高
RVTY
高出14.7%
-2.0%
自由现金流更多
RVTY
多$56.6M
$105.2M
两年增速更快
NET
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $614.5M | $772.1M |
| 净利润 | $-12.1M | $98.4M |
| 毛利率 | 73.6% | — |
| 营业利润率 | -8.0% | 14.5% |
| 净利率 | -2.0% | 12.7% |
| 营收同比 | 33.6% | 5.9% |
| 净利润同比 | 6.0% | 3.9% |
| 每股收益（稀释后） | $-0.03 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NETRVTY
| Q4 25 | $614.5M | $772.1M | ||
| Q3 25 | $562.0M | $698.9M | ||
| Q2 25 | $512.3M | $720.3M | ||
| Q1 25 | $479.1M | $664.8M | ||
| Q4 24 | $459.9M | $729.4M | ||
| Q3 24 | $430.1M | $684.0M | ||
| Q2 24 | $401.0M | $691.7M | ||
| Q1 24 | $378.6M | $649.9M |
净利润NETRVTY
| Q4 25 | $-12.1M | $98.4M | ||
| Q3 25 | $-1.3M | $46.7M | ||
| Q2 25 | $-50.4M | $53.9M | ||
| Q1 25 | $-38.5M | $42.2M | ||
| Q4 24 | $-12.8M | $94.6M | ||
| Q3 24 | $-15.3M | $94.4M | ||
| Q2 24 | $-15.1M | $55.4M | ||
| Q1 24 | $-35.5M | $26.0M |
毛利率NETRVTY
| Q4 25 | 73.6% | — | ||
| Q3 25 | 74.0% | 53.6% | ||
| Q2 25 | 74.9% | 54.5% | ||
| Q1 25 | 75.9% | 56.5% | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 77.7% | 56.3% | ||
| Q2 24 | 77.8% | 55.7% | ||
| Q1 24 | 77.5% | 54.6% |
营业利润率NETRVTY
| Q4 25 | -8.0% | 14.5% | ||
| Q3 25 | -6.7% | 11.7% | ||
| Q2 25 | -13.1% | 12.6% | ||
| Q1 25 | -11.1% | 10.9% | ||
| Q4 24 | -7.5% | 16.3% | ||
| Q3 24 | -7.2% | 14.3% | ||
| Q2 24 | -8.7% | 12.4% | ||
| Q1 24 | -14.4% | 6.8% |
净利率NETRVTY
| Q4 25 | -2.0% | 12.7% | ||
| Q3 25 | -0.2% | 6.7% | ||
| Q2 25 | -9.8% | 7.5% | ||
| Q1 25 | -8.0% | 6.4% | ||
| Q4 24 | -2.8% | 13.0% | ||
| Q3 24 | -3.6% | 13.8% | ||
| Q2 24 | -3.8% | 8.0% | ||
| Q1 24 | -9.4% | 4.0% |
每股收益（稀释后）NETRVTY
| Q4 25 | $-0.03 | $0.86 | ||
| Q3 25 | $0.00 | $0.40 | ||
| Q2 25 | $-0.15 | $0.46 | ||
| Q1 25 | $-0.11 | $0.35 | ||
| Q4 24 | $-0.05 | $0.77 | ||
| Q3 24 | $-0.04 | $0.77 | ||
| Q2 24 | $-0.04 | $0.45 | ||
| Q1 24 | $-0.10 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $943.5M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $7.3B |
| 总资产 | $6.0B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NETRVTY
| Q4 25 | $943.5M | $919.9M | ||
| Q3 25 | $1.1B | $931.4M | ||
| Q2 25 | $1.5B | $991.8M | ||
| Q1 25 | $204.5M | $1.1B | ||
| Q4 24 | $147.7M | $1.2B | ||
| Q3 24 | $182.9M | $1.2B | ||
| Q2 24 | $157.0M | $2.0B | ||
| Q1 24 | $254.4M | $1.7B |
股东权益NETRVTY
| Q4 25 | $1.5B | $7.3B | ||
| Q3 25 | $1.3B | $7.4B | ||
| Q2 25 | $1.2B | $7.6B | ||
| Q1 25 | $1.4B | $7.6B | ||
| Q4 24 | $1.0B | $7.7B | ||
| Q3 24 | $973.1M | $7.9B | ||
| Q2 24 | $881.5M | $7.9B | ||
| Q1 24 | $797.2M | $7.8B |
总资产NETRVTY
| Q4 25 | $6.0B | $12.2B | ||
| Q3 25 | $5.8B | $12.1B | ||
| Q2 25 | $5.6B | $12.4B | ||
| Q1 25 | $3.7B | $12.4B | ||
| Q4 24 | $3.3B | $12.4B | ||
| Q3 24 | $3.1B | $12.8B | ||
| Q2 24 | $2.9B | $13.4B | ||
| Q1 24 | $2.8B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $190.4M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $105.2M | $161.8M |
| 自由现金流率自由现金流/营收 | 17.1% | 21.0% |
| 资本支出强度资本支出/营收 | 13.9% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $287.5M | $509.4M |
8季度趋势，按日历期对齐
经营现金流NETRVTY
| Q4 25 | $190.4M | $182.0M | ||
| Q3 25 | $167.1M | $138.5M | ||
| Q2 25 | $99.8M | $134.3M | ||
| Q1 25 | $145.8M | $128.2M | ||
| Q4 24 | $127.3M | $174.2M | ||
| Q3 24 | $104.7M | $147.9M | ||
| Q2 24 | $74.8M | $158.6M | ||
| Q1 24 | $73.6M | $147.6M |
自由现金流NETRVTY
| Q4 25 | $105.2M | $161.8M | ||
| Q3 25 | $82.5M | $120.0M | ||
| Q2 25 | $39.9M | $115.5M | ||
| Q1 25 | $59.9M | $112.2M | ||
| Q4 24 | $54.2M | $149.8M | ||
| Q3 24 | $54.5M | $125.6M | ||
| Q2 24 | $45.2M | $136.6M | ||
| Q1 24 | $41.5M | $129.7M |
自由现金流率NETRVTY
| Q4 25 | 17.1% | 21.0% | ||
| Q3 25 | 14.7% | 17.2% | ||
| Q2 25 | 7.8% | 16.0% | ||
| Q1 25 | 12.5% | 16.9% | ||
| Q4 24 | 11.8% | 20.5% | ||
| Q3 24 | 12.7% | 18.4% | ||
| Q2 24 | 11.3% | 19.7% | ||
| Q1 24 | 11.0% | 20.0% |
资本支出强度NETRVTY
| Q4 25 | 13.9% | 2.6% | ||
| Q3 25 | 15.1% | 2.6% | ||
| Q2 25 | 11.7% | 2.6% | ||
| Q1 25 | 17.9% | 2.4% | ||
| Q4 24 | 15.9% | 3.4% | ||
| Q3 24 | 11.7% | 3.3% | ||
| Q2 24 | 7.4% | 3.2% | ||
| Q1 24 | 8.5% | 2.7% |
现金转化率NETRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
